Currently out of the existing stock ratings of Richard Purkiss, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).

Richard Purkiss

Work Performance Price Targets & Ratings Chart

Analyst Richard Purkiss, carries an average stock price target met ratio of 95.83% that have a potential upside of 73.13% achieved within 1333 days. Previously, Richard Purkiss worked at PIPER SANDLER.

Richard Purkiss’s has documented 31 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PFE, Pfizer at 13-Nov-2017.

Wall Street Analyst Richard Purkiss

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for PFE (PFIZER) at 11/13/2017. The price target of $51.23 was fulfilled within 1494 days with a profit of $26.51 (107.24%) receiving and performance score of 0.72.

Average potential price target upside

PFE Pfizer ABBV AbbVie LLY Eli Lilly and Company AZN AstraZeneca PLC ADR MRK Merck mpany

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$35

$9.26 (35.98%)

1 months 4 days ago
(24-Nov-2025)

14/21 (66.67%)

$9.78 (38.78%)

564

1.24

Buy

$30

$4.26 (16.55%)

$45

1 months 15 days ago
(13-Nov-2025)

9/38 (23.68%)

$4.13 (15.96%)

842

0.22

Hold

$32

$6.26 (24.32%)

$33

2 months 18 days ago
(10-Oct-2025)

4/22 (18.18%)

$7.22 (29.14%)

356

0.27

Hold

$30

$4.26 (16.55%)

$28

2 months 25 days ago
(03-Oct-2025)

6/10 (60%)

$2.63 (9.61%)

723

1.15

Hold

$25

$-0.74 (-2.87%)

$40

7 months 28 days ago
(30-Apr-2025)

1/5 (20%)

$0.59 (2.42%)

62

0.08

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Richard Purkiss?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?